US Stock Insider Trading | Airdex disclosed one insider transaction on February 12

K-LinePoet · 2026-03-02T04:27:48+00:00

On February 12, 2026, IRIX (IRIX) disclosed an insider trading transaction. Executive Dizon Romeo R purchased 1,500 shares.【Recent Insider Trading】| Disclosure Date | Position | Name | Transaction Date | Buy/Sell | Quantity | Price per Share/USD | Total Amount/USD || --- | --- | --- | --- | --- | --- | --- | --- || February 12, 2026 | Executive | Dizon Romeo R | February 12, 2026 | Buy | 1500 | 1.43 | 2145.00 || February 10, 2026 | Executive |

K-LinePoet

2026-03-02 04:27:48

On February 12, 2026, Iridex (IRIX) disclosed an insider transaction. Executive Dizon Romeo R purchased 1,500 shares.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 12, 2026	Executive	Dizon Romeo R	February 12, 2026	Buy	1,500	1.43	2,145.00
February 10, 2026	Executive	Dizon Romeo R	February 10, 2026	Buy	1,000	1.46	1,460.00
February 3, 2026	Executive	Dizon Romeo R	February 3, 2026	Buy	2,500	1.38	3,450.00
January 29, 2026	Executive	Dizon Romeo R	January 29, 2026	Buy	1,101	1.44	1,587.64
January 28, 2026	Executive	Dizon Romeo R	January 28, 2026	Buy	1,300	1.46	1,898.00
January 27, 2026	Executive	Dizon Romeo R	January 27, 2026	Buy	3,385	1.48	5,009.46
January 26, 2026	Executive	Dizon Romeo R	January 26, 2026	Buy	1,243	1.52	1,889.36
January 23, 2026	Executive	Dizon Romeo R	January 23, 2026	Buy	5,221	1.48	7,716.12
January 21, 2026	Executive	Dizon Romeo R	January 21, 2026	Buy	1,750	1.49	2,607.50
January 21, 2026	Executive	Dizon Romeo R	January 21, 2026	Buy	409	1.53	625.77

[Company Profile]

Iridex Corporation was founded in February 1989 in California, originally named IRIS Medical Instruments. In November 1995, the company was renamed Iridex Corporation in Delaware. The company is an ophthalmic medical technology firm focused on developing and commercializing breakthrough products and procedures for treating eye diseases that threaten vision, including glaucoma and retinal diseases.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.